Vogl, NY

 

Avatar

SABCS 2020 RxPONDER Updates on HR+ Node-Positive EBC: Are Postmenopausal Women Able to Avoid Chemotherapy?

By Steven Vogl 18 Videos
2,051 views
December 29, 2020
Comments 1
Login to view comments. Click here to Login

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
Breast
54:19

Adjuvant Abemaciclib - Are The Data Sufficient? Maybe

Steven Vogl

265 views
48:18

SABCS 2021 Update: SOFT and TEXT are Important - Ovarian Function Su…

Steven Vogl

762 views
25:09

SABCS 2021 on Using the Appearance of a Resistance Mutation in Perip…

SABCS 2021 Conference Coverage on VuMedi

S. Vogl

479 views
32:47

SABCS 2021 Updated Results From the RxPONDER Trial in HR+/HER2- Brea…

SABCS 2021 Conference Coverage on VuMedi

S. Vogl

1.4K views
27:32

We Need Overall Survival Results From Keynote 355 Now!

Steven Vogl

819 views
47:44

Ovarian Suppression or Cytotoxic Chemotherapy: What Is the Mechanism…

Steven Vogl

1.2K views
29:48

SABCS 2020 RxPONDER Updates on HR+ Node-Positive EBC: Are Postmenopa…

Steven Vogl

2.1K views
18:37

POOF: And the Benefit Disappeared! What We Learn From PenelopeB. A N…

Steven Vogl

1.5K views
25:41

Do PD-1 Drugs Really Help Patients With mTNBC to Live Longer and Bet…

Steven Vogl

1.5K views
30:31

Discussion on 2020 ESMO Update on CDK4/6i in Adjuvant ER+ Resected B…

Steven Vogl

1.3K views